KR920701244A - 심실 펩티드 유도체 - Google Patents
심실 펩티드 유도체Info
- Publication number
- KR920701244A KR920701244A KR1019910700087A KR910700087A KR920701244A KR 920701244 A KR920701244 A KR 920701244A KR 1019910700087 A KR1019910700087 A KR 1019910700087A KR 910700087 A KR910700087 A KR 910700087A KR 920701244 A KR920701244 A KR 920701244A
- Authority
- KR
- South Korea
- Prior art keywords
- arg
- amino acid
- effective amount
- therapeutically effective
- administering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (11)
- 하기 일반식의 화합물 또는 이의 약제학적으로 허용되는 염, 에스테르 또는 아미드.상기 식에서, R1은 수소 아세틸, Arg, Aha, Arg, Cit, His, Lys, Orn 및 Ser-Ser중에서 선택되고; R2는 황-함유 그룹이며; R3는 소수성 아미노산 또는 디펩타이드이고; R4는 디펩타디이드 스페이서 또는 식 X-Y(여기서, X는 디펩타이드 스페이서이고 Y는 염기성 아미노산 이다)의 트리펩타이드이며; R5는 소수성 아미노산이고; R6는 아미노산 3개 이하의 펩타이드이며; R7는 Cha, Pha, Cha-Arg, Phe-Arg, (D)Phe-Arg, Phe-(D)Arg, PheArg, Leu-Arg, Ala-Arg, Arg 및 Cly-Ala중에서 선택되고, R8은 황-함유 그룹이다.
- 제1항에 있어서, R1이 여기성 아미노산이고; R3이 사이클로알킬을 함유하는 소수성 아미노산이며; R6이 산성 아미노산을 함유하는 아미노산 3개 이하의 펩타이드인 화합물.
- 제1항에 있어서, R1이 수소이고; R2가 메르캅토프로피온산이며; R3가 사이클로알킬을 함유하는 소수성 아미노산이고; R6이-산성 아미노산을 함유하는 아미노산 3개 이하의 펩타이드인 화합물.
- ; 중에서 선택된 화합물 또는 이 약제학적으로 허용되는 염, 에스테르 또는 아미드.
- 치료학적 유효량의 제1항에 따른 화합물 및 약제학적으로 허용되는 담체 또는 희석제를 함유하는 약제학적 조성물.
- 나트륨뇨배설항진을 필요로 하는 환자에게 치료학적 유효량의 제1항에 다른 화합물을 투여함을 특징으로 하여 나트륨뇨배설항진을 초래하는 방법.
- 이뇨를 필요로 하는 환자에게 치료학적 유효량의 제1항에 따른 화합물을 투여함을 특징으로 하여 이뇨를 초래하는 방법.
- 신혈관확장을 필요로 하는 환자에게 치료학적 유효량의 제1항에 따른 화합물을 투여함을 특징으로 하여 신혈관확장을 초래하는 방법.
- 신장보호를 필요로 하는 환자에게 치료학적 유효량의 제1항에 따른 화합물을 투여함을 특징으로 하여, 신장을 보호하는 방법.
- ANP-관련질환치료를 필요로 하는 환자에게 치료학적 유효량의 제1항에 따른 화합물을 투여함을 특징으로 하여, ANP-관련 질환을 치료하는 방법.
- 제10항에 있어서, ANP-관련 질환이 고혈압, 신부전증, 뇌부종, 울혈성심마비 및 경변증 중에서 선택되는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35698089A | 1989-05-24 | 1989-05-24 | |
US356980 | 1989-05-24 | ||
PCT/US1990/002917 WO1990014362A1 (en) | 1989-05-24 | 1990-05-23 | Atrial peptide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
KR920701244A true KR920701244A (ko) | 1992-08-11 |
Family
ID=23403792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910700087A KR920701244A (ko) | 1989-05-24 | 1990-05-23 | 심실 펩티드 유도체 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0431113A4 (ko) |
JP (1) | JPH04500363A (ko) |
KR (1) | KR920701244A (ko) |
AU (1) | AU5827690A (ko) |
CA (1) | CA2033198A1 (ko) |
GR (1) | GR1001018B (ko) |
IL (1) | IL94487A0 (ko) |
NZ (1) | NZ233795A (ko) |
WO (1) | WO1990014362A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5208218A (en) * | 1988-09-19 | 1993-05-04 | Ludwig Institute For Cancer Research | T cell growth factor glycoproteins |
US5665704A (en) * | 1993-11-12 | 1997-09-09 | Genentech, Inc. | Receptor specific atrial natriuretic peptides |
US6525022B1 (en) | 1993-11-12 | 2003-02-25 | Genentech, Inc. | Receptor specific atrial natriuretic peptides |
US5846932A (en) * | 1993-11-12 | 1998-12-08 | Genentech, Inc. | Receptor specific atrial natriuretic peptides |
EP1530588A2 (en) * | 2002-07-31 | 2005-05-18 | Conjuchem, Inc. | Long lasting natriuretic peptide derivatives |
EP2004633A4 (en) | 2006-03-30 | 2009-08-26 | Palatin Technologies Inc | LINEAR CONSTRUCTIONS OF NATRIURETIC PEPTIDES |
US8580746B2 (en) | 2006-03-30 | 2013-11-12 | Palatin Technologies, Inc. | Amide linkage cyclic natriuretic peptide constructs |
AU2007233116B2 (en) | 2006-03-30 | 2013-05-09 | Palatin Technologies, Inc. | Cyclic natriuretic peptide constructs |
WO2011098095A1 (en) * | 2010-02-09 | 2011-08-18 | Aplagen Gmbh | Peptides binding the tpo receptor |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4757048A (en) * | 1985-11-05 | 1988-07-12 | Biotechnology Research Associates J.V. | Synthetic analogs of atrial natriuretic peptides |
KR940001711B1 (ko) * | 1985-11-05 | 1994-03-05 | 캘리포니아 바이오테크널러지 인코포레이티드 | 심방성 나트륨이뇨성 펩티드의 동족체 |
US4721704A (en) * | 1986-05-09 | 1988-01-26 | Peninsula Laboratories, Inc. | Potent synthetic atrial peptide analogs |
US4804650A (en) * | 1986-10-28 | 1989-02-14 | Biotechnology Research Associates, J.V. | Analogs of atrial natriuretic peptides |
EP0271041A3 (en) * | 1986-12-10 | 1990-04-11 | Abbott Laboratories | Atrial peptide derivatives |
EP0292256A3 (en) * | 1987-05-19 | 1990-10-03 | Merck & Co. Inc. | Peptides having anf activity |
US4935492A (en) * | 1987-12-24 | 1990-06-19 | California Biotechnology Inc. | Cyclic analogs of atrial natriuretic peptides |
-
1990
- 1990-05-23 EP EP19900909101 patent/EP0431113A4/en not_active Withdrawn
- 1990-05-23 GR GR900100396A patent/GR1001018B/el unknown
- 1990-05-23 CA CA002033198A patent/CA2033198A1/en not_active Abandoned
- 1990-05-23 KR KR1019910700087A patent/KR920701244A/ko not_active Application Discontinuation
- 1990-05-23 AU AU58276/90A patent/AU5827690A/en not_active Abandoned
- 1990-05-23 WO PCT/US1990/002917 patent/WO1990014362A1/en not_active Application Discontinuation
- 1990-05-23 JP JP2508785A patent/JPH04500363A/ja active Pending
- 1990-05-24 NZ NZ233795A patent/NZ233795A/en unknown
- 1990-05-24 IL IL94487A patent/IL94487A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NZ233795A (en) | 1992-07-28 |
CA2033198A1 (en) | 1990-11-25 |
AU5827690A (en) | 1990-12-18 |
GR900100396A (en) | 1991-10-10 |
WO1990014362A1 (en) | 1990-11-29 |
EP0431113A1 (en) | 1991-06-12 |
JPH04500363A (ja) | 1992-01-23 |
EP0431113A4 (en) | 1992-01-22 |
IL94487A0 (en) | 1991-03-10 |
GR1001018B (el) | 1993-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2510840T3 (es) | Compuestos para la inhibición enzimática del proteosoma | |
US5602098A (en) | Inhibition of farnesyltransferase | |
US4277394A (en) | Tetrapeptidehydrazide derivatives | |
AU582600B2 (en) | Dipeptide compounds having pharmaceutical activity and compositions containing them | |
KR900002560B1 (ko) | 신규 펩티드 화합물의 제법 | |
CA1286846C (en) | Peptide derivatives which inhibit renin and acid proteases | |
US4619916A (en) | Tripeptide compounds containing pyroglutamic acid and tryptophan, process for their production and therapeutic applications | |
PT1948678E (pt) | Compostos para inibição de enzimas | |
JPH0680079B2 (ja) | ポリペプチド | |
KR900002801A (ko) | 당뇨병 치료용 약학적제제 | |
EP0111266A2 (de) | Substituierte Tetrapeptide | |
RU2223970C2 (ru) | Лечение ожирения | |
GB2045771A (en) | Mercaptoacyldipeptides | |
EP0317573B1 (en) | Antipyretic and anti-inflammatory peptides | |
KR920701244A (ko) | 심실 펩티드 유도체 | |
KR900003205A (ko) | 제약 화합물 | |
US4439360A (en) | Retro-inverso analogues of C-terminal penta and hexapeptides of Substance P | |
US5079231A (en) | Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them | |
US3912705A (en) | Thyrotropin releasing hormone analogs | |
EP0516851B1 (en) | Physiologically active substance well capable of permeating biomembrane | |
US4579841A (en) | Dipeptide derivatives having opiate activity | |
HU184481B (en) | Process for producing tripeptides for diminishing appetite | |
US3268502A (en) | Undecapeptides | |
FI82837C (fi) | Foerfarande foer framstaellning av gonadoliberinderivat, som inverkar pao de reproduktiva processerna hos djur. | |
KR890014735A (ko) | 변형 단백질 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |